Cargando…
2432. Durability Against Antibiotics After Response to Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
BACKGROUND: Fecal microbiota transplantation (FMT) cures ~90% of patients with recurrent Clostridioides difficile infection (rCDI). Ongoing or repeated exposure to risk factors, especially antibiotics (a modifiable risk factor but often necessary), may lead to future CDI. However, it is not known if...
Autores principales: | Saha, Srishti, Tariq, Raseen, Pardi, Ryan, Pardi, Darrell, Khanna, Sahil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809543/ http://dx.doi.org/10.1093/ofid/ofz360.2110 |
Ejemplares similares
-
Resolution rates in clinical trials for microbiota restoration for
recurrent Clostridioides difficile infection: an updated
systematic review and meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2023) -
Incidence of Clostridioides difficile infection in peripartum women: a retrospective cohort study
por: Saha, Srishti, et al.
Publicado: (2020) -
Effect of peripartum Clostridioides difficile
infection on pregnancy and neonatal outcomes: an observational
study
por: Saha, Srishti, et al.
Publicado: (2023) -
Kinetics of polymerase chain reaction positivity in patients with Clostridioides difficile infection
por: Saha, Srishti, et al.
Publicado: (2021) -
Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis
por: Tariq, Raseen, et al.
Publicado: (2021)